In breast cancer, the knockout of the ATPase subunit SMARCA4 of the SWI/SNF chromatin remodeling complex is associated with cisplatin resistance in triple-negative breast cancer cells. Here, SMARCA1 is linked to triple-negative breast carcinoma.